Home Call for Abstract

Abstract

The APSCI 2027 invites you to submit your abstract(s) at this wonderful gathering of knowledge and experiences and contribute with your in-depth studies to the field of cochlear implant and related sciences.

Submit Abstract

Important Dates

Abstract Submission Deadline

June 30, 2027

Notification of Acceptance

August 31, 2027

 

Abstract Topics

  • 01 - Genetics and omics: Diagnosis/Prediction
  • 02 - Audiological Examination & Intraoperative Monitoring
  • 03 - Radiology
  • 04 - Gene Therapy & Cell Therapy
  • 05 - Robotics
  • 06 - Surgical Issues and Complications
  • 07 - Hearing Preservation & Bimodal Hearing
  • 08 - Inner Ear Anomaly
  • 09 - Sequential CI, Asymmetric/SSD, prelingual deafness
  • 10 - Elderly CI & Cognition
  • 11 - Central Auditory Pathway & Brain Plasticity
  • 12 - CI in Lateral Skull Base Tumors
  • 13 - Coding Strategy & Electrode array design
  • 14 - Mapping, Rehabilitation & Speech Therapy
  • 15 - Vestibule & Tinnitus
  • 16 - Music Perception & QOL
  • 17 - Totally implantable CI
  • 18 - Vestibular Implant
  • 19 - Auditory Brainstem Implant
  • 20 - Brain Computer Interface
  • 21 - Bone Anchored Hearing aids
  • 22 - Public Awareness/Public Health
  • 23 - Miscellaneous
  • 24 - Young Award session


Abstract Submission Guidelines

Submission

  - Abstract can only be submitted online through the official website. Abstract submission by email or fax will not be accepted.
  - Submission of an abstract implies that it has been approved by all listed authors.

Language

  - English

Title

  - The title must not exceed 30 words.
  - Refrain from using abbreviations in the title.

Author

  - Names and surnames for all co-authors must be provided.
  - Do not include degrees or titles.
  - Presenting author's name will be underlined, and corresponding author's name will be in bold.

Institution

  - Listed by department, institution and country.

Contents

  - Contents may be organized as the author sees fit, though they should include the purpose of the study, the methods used, a summary of the results and the conclusion reached. It is not satisfactory to simply state that "The result will be discussed."
  - The contents must not exceed 300 words.
  - Tables, figures, graphs and references are not allowed in the abstract.
  - Animated images and animations are not permitted and will be non-functioning.
  - All abbreviations must be defined in first use. Only standard abbreviations may be used without definition. Data must be given in units widely used in literature (An international metric system is preferred).
  - Abstracts will be reproduced exactly as submitted and will not be edited in any way. The authors are responsible for all spelling, grammatical or scientific errors.
  - Modifications may be made at any time until the abstract submission deadline.

Keywords

  - 3-5 keywords must be entered.

Originality

  - Abstracts must be original and must not have been published at the time of abstract submission.

Conflicts of Interest

  - To avoid any commercial bias, all authors must disclose conflicts of interest in the presentation.

Copyright

  - By submitting the abstract, the author(s) grants APSCI 2027 the exclusive right to first publish the abstract and thereafter a non-exclusive right to publish,display and store the abstract in all forms formats, and media.
  - No fee shall be paid to the author(s) by APSCI 2027 for the license granted herein. The author(s) will retain the copyright of his or her abstract as well.

 

 

Copyright Protection

All materials presented and/or published at the 16th APSCI are valuable research assets. The Organizing Committee of the 16th APSCI strictly prohibits duplication, reproduction, storage and/or transmission for any commercial purpose.

 

Unauthorized reproduction, distribution, transmission, and commercial use of any presented and/or published materials of the 16th APSCI is a serious offense of copyright infringement, and upon violation of such conducts, the Organizing Committee may take civil and criminal legal actions against them.